Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

1.505 +0.025 (+1.69%)

Delayed Quote Updated: 11:22 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More ↗

June 30, 2021

Institutional analysts are taking a liking to the industry ...

Via Benzinga

60 Biggest Movers From Yesterday ↗

June 29, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 28, 2021

Gainers SCWorx (NASDAQ:WORX) shares rose ...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2021 ↗

June 28, 2021

Upgrades For Toll Brothers Inc (NYSE:

Via Benzinga

Privately Owned MagicMed Industries Inc. is Psyched to Join Forces with Public Pharma Co. Enveric ↗

June 23, 2021

MagicMed Industries Inc., a privately-held biotech company, recently announced its agreement to an acquisition by Enveric Biosciences (NASDAQ: ENVB). This joint venture may be the...

Via Benzinga

CEO Presenting on the Emerging Growth Conference on June 9. Register here

June 07, 2021

Niche Companies in Technology, Biotech, Precious Metals, and more in Attendance

Via EIN Presswire

EXCLUSIVE: MagicMed CEO On Psychedelics Company's 'Secret Sauce,' M&A Deal With Enveric Biosciences ↗

June 04, 2021

MagicMed Industries' focus is on creating new molecules based on psychedelics, said CEO Dr. Joseph Tucker — bu...

Via Benzinga

ENVERIC BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Enveric Biosciences, Inc. - ENVB

June 01, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 01, 2021

Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA

Via Benzinga

Enveric Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Enveric Biosciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ENVB

June 01, 2021

From Halper Sadeh LLP

Via Business Wire

Psyched: Nasdaq Gets Its Third Psychedelics Company, Mynd Goes Public, Delic Buys New Research Facility ↗

May 28, 2021

The Nasdaq welcomed its third psychedelics company this week, with

Via Benzinga

52 Biggest Movers From Yesterday ↗

May 25, 2021

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 24, 2021

Gainers Scopus BioPharma (NASDAQ:SCPS) stock rose 101.34% to $12.0 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 17.5...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

May 24, 2021

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 123.7% to $13.33 after the company reported the FDA approval of IND application for CpG-STAT3siRNA, its distinctive...

Via Benzinga

Another Psychedelics Company Joins 'Exclusive Nasdaq Group' With Enveric's Acquisition Of MagicMed Industries ↗

May 24, 2021

CBD-focused biotechnology company Enveric Biosciences (NASDAQ:...

Via Benzinga

30 Stocks Moving In Friday's Mid-Day Session ↗

May 21, 2021

Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares jumped 105.4% to $54.23 after the company announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401,...

Via Benzinga

48 Biggest Movers From Friday ↗

May 24, 2021

Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 21, 2021

Gainers Enveric Biosciences (NASDAQ:ENVB) stock rose 16.87% to $2.84 during Friday's pre-market session. The company's, Q1 earnings came out 3 days ago....

Via Benzinga

21 Stocks Moving in Friday's Pre-Market Session ↗

May 21, 2021

Gainers Enveric Biosciences, Inc. (NASDAQ: ENVB) rose 13.2% to $2.75 in pre-market trading after climbing over 11% on Thursday. The company recently reported a Q1 loss of $0.20...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 20, 2021

Gainers Enveric Biosciences (NASDAQ:ENVB)...

Via Benzinga

60 Biggest Movers From Yesterday ↗

April 29, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of...

Via Benzinga

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts ↗

May 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week ↗

April 25, 2021

Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC.

Via Talk Markets

The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗

April 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 21, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE) stock rose 23.16% to $1.54 during Wednesday's pre-market session. The company's market cap stands at $53.4 million....

Via Benzinga

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021

April 19, 2021

LOS ANGELES, CA / ACCESSWIRE / April 19, 2021 / The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be...

From Stock News Now

Via AccessWire

Topics Cannabis

The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs ↗

April 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.